UPS
BMY icon

UHLMANN PRICE SECURITIES’s Bristol-Myers Squibb BMY Stock Holding History

UHLMANN PRICE SECURITIES’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Buy
17,169
+1,328
+8% +$76.3K 0.04% 81
2026
Q1 		$927K Buy
15,841
+10,036
+173% +$585K 0.06% 70
2025
Q4 		$313K Buy
5,805
+377
+7% +$18.1K 0.19% 125
2025
Q3 		$245K Sell
5,428
-723
-12% -$33.8K 0.15% 150
2025
Q2 		$285K Sell
6,151
-1,603
-21% -$78.7K 0.2% 121
2025
Q1 		$473K Buy
7,754
+467
+6% +$27.2K 0.35% 75
2024
Q4 		$412K Buy
7,287
+8
+0.1% +$447 0.31% 84
2024
Q3 		$377K Buy
+7,279
New +$341K 0.3% 91

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

UHLMANN PRICE SECURITIES's BMY Position: Q2 2026 in Review

UHLMANN PRICE SECURITIES increased its Bristol-Myers Squibb (BMY) stake by 8.4% in Q2 2026, buying an estimated $76.3K and bringing the position to 17,169 shares worth $989K. The position accounts for 0.04% of the portfolio, ranked #81.

UHLMANN PRICE SECURITIES first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • UHLMANN PRICE SECURITIES held 17,169 shares of Bristol-Myers Squibb worth $989K as of Q2 2026.
  • UHLMANN PRICE SECURITIES bought 1,328 Bristol-Myers Squibb shares in Q2 2026, an estimated $76.3K.
  • Bristol-Myers Squibb made up 0.04% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #81 holding.
  • UHLMANN PRICE SECURITIES first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.